Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13 Esophageal Squamous Cell Carcinoma 7 Carcinoma, Non-Small-Cell Lung 5 Stomach Neoplasms 4 Rectal Neoplasms 4 Neoplasms 4 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of External Auditory Canal 1 Seminoma 1 Recurrence 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 Muscle Invasive Bladder Cancer 1

Interventions

pembrolizumab 3 toripalimab 2 Celecoxib 2 sintilimab 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 denileukin diftitox 1 camrelizumab 1 Radiation Dose Hypofractionation 1 Nivolumab 1 Neoadjuvant Therapy 1 Ipilimumab 1 Interleukin-2 1 E7777 fusion protein 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Turcot syndrome × Neoadjuvant Therapy × Clear all

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡